You are here: Industry Insights > RDIF

News List

Russia to supply Mexico with 32 million doses of Sputnik V europeanpharmaceuticalreview
September 24, 2020
The Russian Direct Investment Fund (RDIF) said the supply of the COVID-19 vaccine should enable 25 percent of the population to be vaccinated.
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India expresspharma
September 17, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.
Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19 pharmaceutical-technology
July 06, 2020
A joint venture established by the Russian Direct Investment Fund (RDIF) and ChemRar Group is set to boost production of Avifavir, which secured temporary approval from the Russian government to treat Covid-19.
Russia to roll out its first approved COVID-19 drug next week expresspharma
June 03, 2020
Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview.
Russia grants temporary approval for Avifavir to treat Covid-19 pharmaceutical-technology
June 02, 2020
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and ChemRar Group.

Previous page 1 2 3 4 5 Next page